In the world economic growth, the Mitomycin C industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Mitomycin C market size to maintain the average annual growth rate of XXX from XXX million $ in 2014 to XXX million $ in 2019, SMI analysts believe that in the next few years, Mitomycin C market size will be further expanded, we expect that by 2024, The market size of the Mitomycin C will reach XXX million $.
Mitomycin C is the most common mitomycin used in the treatment of urinary tract infections. It is usually given intravenously for the treatment of bladder cancer, upper gastrointestinal cancers, and anal cancers. Its drug-related activities include the ability to eliminate bacteria, minimize or inhibit the effect of other drugs on cell structure, enhance the effect of drugs on the immune system, and slow or minimize the effect of biological stress on cells and tissues. It has recently been discovered that mitomycin C, an oral antibiotic, possesses cytotoxic (cell-killing) properties. This property was found after the isolation and evaluation of a type of fungi called E-coli. This study provided evidence that the combination of this drug with other antifungal agents could produce a highly potent combination that has the ability to destroy all types of bacteria, fungi, and viruses when administered intravenously.
The growing prevalence of cancer around is driving the growth of the mitomycin C market. Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020 (1). The most common in 2020 were: breast (2.26 million cases), lung (2.21 million cases), colon and rectum (1.93 million cases), prostate (1.41 million cases), and stomach (1.09 million cases). Mitomycin C is an affordable option than other treatment methods which has also given the boost the demand for mitomycin. This drug is widely used in the treatment of melanoma, lung cancer, blood cancer, prostate cancer, breast cancer, colorectal cancer, and several ophthalmic treatments. Moreover, it has also gained popularity in ophthalmology in recent years. Currently, it is used in cicatricial eye disease, glaucoma surgery, pterygium surgery, conjunctival neoplasia, corneal refractive surgery, and allergic eye disease.
North America is expected to exhibit significant growth over the forecast period and this is attributed to the increasing drug approval FDA in order to meet the growing demand. For instance, in April 2020, the Food and Drug Administration approved mitomycin (JELMYTO, UroGen Pharma) for adult patients with low-grade upper tract urothelial cancer (LG-UTUC).
Key Developments:
- In January 2019, Hikma Pharmaceuticals PLC (Hikma, Group) announces that Hikma Pharmaceuticals USA Inc., formerly known as West-Ward Pharmaceuticals Corp., has launched Mitomycin for Injection, USP, 20mg and 40mg
- In April 2020, UroGen Pharma receives U.S. FDA Expedited Approval for Jelmyto™, the first and only non-surgical treatment for patients with low-grade upper tract urothelial cancer
This Report covers the manufacturers' data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data.
Besides, the report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers. If you need more information, please contact SMI
Section 1: Definition
Section (2 3): Manufacturer Detail
Kyowa-kirin
Intas Pharmaceuticals
Teva
Bristol-Myers Squibb
Aspen
Speciality European Pharma
Alkem Laboratories
Varifarma
APOGEPHA
Section 4: Region Segmentation
North America Country (United States, Canada)
South America
Asia Country (China, Japan, India, Korea)
Europe Country (Germany, UK, France, Italy)
Other Country (Middle East, Africa, GCC)
Section (5 6 7):
Product Type Segmentation
2 Mg
10 Mg
40 Mg
Industry Segmentation
Cancer Treatment
Ophthalmic Use
Channel (Direct Sales, Distributor) Segmentation
Section 8: Trend (2019-2024)
Section 9: Product Type Detail
Section 10: Downstream Consumer
Section 11: Cost Structure
Section 12: Conclusion
Table of Contents
Section 1 Mitomycin C Product Definition
Section 2 Global Mitomycin C Market Manufacturer Share and Market Overview
2.1 Global Manufacturer Mitomycin C Shipments
2.2 Global Manufacturer Mitomycin C Business Revenue
2.3 Global Mitomycin C Market Overview
Section 3 Manufacturer Mitomycin C Business Introduction
3.1 Kyowa-kirin Mitomycin C Business Introduction
3.1.1 Kyowa-kirin Mitomycin C Shipments, Price, Revenue and Gross profit 2014-2019
3.1.2 Kyowa-kirin Mitomycin C Business Distribution by Region
3.1.3 Kyowa-kirin Interview Record
3.1.4 Kyowa-kirin Mitomycin C Business Profile
3.1.5 Kyowa-kirin Mitomycin C Product Specification
3.2 Intas Pharmaceuticals Mitomycin C Business Introduction
3.2.1 Intas Pharmaceuticals Mitomycin C Shipments, Price, Revenue and Gross profit 2014-2019
3.2.2 Intas Pharmaceuticals Mitomycin C Business Distribution by Region
3.2.3 Interview Record
3.2.4 Intas Pharmaceuticals Mitomycin C Business Overview
3.2.5 Intas Pharmaceuticals Mitomycin C Product Specification
3.3 Teva Mitomycin C Business Introduction
3.3.1 Teva Mitomycin C Shipments, Price, Revenue and Gross profit 2014-2019
3.3.2 Teva Mitomycin C Business Distribution by Region
3.3.3 Interview Record
3.3.4 Teva Mitomycin C Business Overview
3.3.5 Teva Mitomycin C Product Specification
3.4 Bristol-Myers Squibb Mitomycin C Business Introduction
3.5 Aspen Mitomycin C Business Introduction
3.6 Speciality European Pharma Mitomycin C Business Introduction
…
Section 4 Global Mitomycin C Market Segmentation (Region Level)
4.1 North America Country
4.1.1 United States Mitomycin C Market Size and Price Analysis 2014-2019
4.1.2 Canada Mitomycin C Market Size and Price Analysis 2014-2019
4.2 South America Country
4.2.1 South America Mitomycin C Market Size and Price Analysis 2014-2019
4.3 Asia Country
4.3.1 China Mitomycin C Market Size and Price Analysis 2014-2019
4.3.2 Japan Mitomycin C Market Size and Price Analysis 2014-2019
4.3.3 India Mitomycin C Market Size and Price Analysis 2014-2019
4.3.4 Korea Mitomycin C Market Size and Price Analysis 2014-2019
4.4 Europe Country
4.4.1 Germany Mitomycin C Market Size and Price Analysis 2014-2019
4.4.2 UK Mitomycin C Market Size and Price Analysis 2014-2019
4.4.3 France Mitomycin C Market Size and Price Analysis 2014-2019
4.4.4 Italy Mitomycin C Market Size and Price Analysis 2014-2019
4.4.5 Europe Mitomycin C Market Size and Price Analysis 2014-2019
4.5 Other Country and Region
4.5.1 Middle East Mitomycin C Market Size and Price Analysis 2014-2019
4.5.2 Africa Mitomycin C Market Size and Price Analysis 2014-2019
4.5.3 GCC Mitomycin C Market Size and Price Analysis 2014-2019
4.6 Global Mitomycin C Market Segmentation (Region Level) Analysis 2014-2019
4.7 Global Mitomycin C Market Segmentation (Region Level) Analysis
Section 5 Global Mitomycin C Market Segmentation (Product Type Level)
5.1 Global Mitomycin C Market Segmentation (Product Type Level) Market Size 2014-2019
5.2 Different Mitomycin C Product Type Price 2014-2019
5.3 Global Mitomycin C Market Segmentation (Product Type Level) Analysis
Section 6 Global Mitomycin C Market Segmentation (Industry Level)
6.1 Global Mitomycin C Market Segmentation (Industry Level) Market Size 2014-2019
6.2 Different Industry Price 2014-2019
6.3 Global Mitomycin C Market Segmentation (Industry Level) Analysis
Section 7 Global Mitomycin C Market Segmentation (Channel Level)
7.1 Global Mitomycin C Market Segmentation (Channel Level) Sales Volume and Share 2014-2019
7.2 Global Mitomycin C Market Segmentation (Channel Level) Analysis
Section 8 Mitomycin C Market Forecast 2019-2024
8.1 Mitomycin C Segmentation Market Forecast (Region Level)
8.2 Mitomycin C Segmentation Market Forecast (Product Type Level)
8.3 Mitomycin C Segmentation Market Forecast (Industry Level)
8.4 Mitomycin C Segmentation Market Forecast (Channel Level)
Section 9 Mitomycin C Segmentation Product Type
9.1 2 Mg Product Introduction
9.2 10 Mg Product Introduction
9.3 40 Mg Product Introduction
Section 10 Mitomycin C Segmentation Industry
10.1 Cancer Treatment Clients
10.2 Ophthalmic Use Clients
Section 11 Mitomycin C Cost of Production Analysis
11.1 Raw Material Cost Analysis
11.2 Technology Cost Analysis
11.3 Labor Cost Analysis
11.4 Cost Overview
Section 12 Conclusion
Chart and Figure
Figure Mitomycin C Product Picture from Kyowa-kirin
Chart 2014-2019 Global Manufacturer Mitomycin C Shipments (Units)
Chart 2014-2019 Global Manufacturer Mitomycin C Shipments Share
Chart 2014-2019 Global Manufacturer Mitomycin C Business Revenue (Million USD)
Chart 2014-2019 Global Manufacturer Mitomycin C Business Revenue Share
Chart Kyowa-kirin Mitomycin C Shipments, Price, Revenue and Gross profit 2014-2019
Chart Kyowa-kirin Mitomycin C Business Distribution
Chart Kyowa-kirin Interview Record (Partly)
Figure Kyowa-kirin Mitomycin C Product Picture
Chart Kyowa-kirin Mitomycin C Business Profile
Table Kyowa-kirin Mitomycin C Product Specification
Chart Intas Pharmaceuticals Mitomycin C Shipments, Price, Revenue and Gross profit 2014-2019
Chart Intas Pharmaceuticals Mitomycin C Business Distribution
Chart Intas Pharmaceuticals Interview Record (Partly)
Figure Intas Pharmaceuticals Mitomycin C Product Picture
Chart Intas Pharmaceuticals Mitomycin C Business Overview
Table Intas Pharmaceuticals Mitomycin C Product Specification
Chart Teva Mitomycin C Shipments, Price, Revenue and Gross profit 2014-2019
Chart Teva Mitomycin C Business Distribution
Chart Teva Interview Record (Partly)
Figure Teva Mitomycin C Product Picture
Chart Teva Mitomycin C Business Overview
Table Teva Mitomycin C Product Specification
3.4 Bristol-Myers Squibb Mitomycin C Business Introduction
…
Chart United States Mitomycin C Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart United States Mitomycin C Sales Price ($/Unit) 2014-2019
Chart Canada Mitomycin C Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart Canada Mitomycin C Sales Price ($/Unit) 2014-2019
Chart South America Mitomycin C Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart South America Mitomycin C Sales Price ($/Unit) 2014-2019
Chart China Mitomycin C Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart China Mitomycin C Sales Price ($/Unit) 2014-2019
Chart Japan Mitomycin C Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart Japan Mitomycin C Sales Price ($/Unit) 2014-2019
Chart India Mitomycin C Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart India Mitomycin C Sales Price ($/Unit) 2014-2019
Chart Korea Mitomycin C Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart Korea Mitomycin C Sales Price ($/Unit) 2014-2019
Chart Germany Mitomycin C Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart Germany Mitomycin C Sales Price ($/Unit) 2014-2019
Chart UK Mitomycin C Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart UK Mitomycin C Sales Price ($/Unit) 2014-2019
Chart France Mitomycin C Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart France Mitomycin C Sales Price ($/Unit) 2014-2019
Chart Italy Mitomycin C Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart Italy Mitomycin C Sales Price ($/Unit) 2014-2019
Chart Europe Mitomycin C Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart Europe Mitomycin C Sales Price ($/Unit) 2014-2019
Chart Middle East Mitomycin C Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart Middle East Mitomycin C Sales Price ($/Unit) 2014-2019
Chart Africa Mitomycin C Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart Africa Mitomycin C Sales Price ($/Unit) 2014-2019
Chart GCC Mitomycin C Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart GCC Mitomycin C Sales Price ($/Unit) 2014-2019
Chart Global Mitomycin C Market Segmentation (Region Level) Sales Volume 2014-2019
Chart Global Mitomycin C Market Segmentation (Region Level) Market size 2014-2019
Chart Mitomycin C Market Segmentation (Product Type Level) Volume (Units) 2014-2019
Chart Mitomycin C Market Segmentation (Product Type Level) Market Size (Million $) 2014-2019
Chart Different Mitomycin C Product Type Price ($/Unit) 2014-2019
Chart Mitomycin C Market Segmentation (Industry Level) Market Size (Volume) 2014-2019
Chart Mitomycin C Market Segmentation (Industry Level) Market Size (Share) 2014-2019
Chart Mitomycin C Market Segmentation (Industry Level) Market Size (Value) 2014-2019
Chart Global Mitomycin C Market Segmentation (Channel Level) Sales Volume (Units) 2014-2019
Chart Global Mitomycin C Market Segmentation (Channel Level) Share 2014-2019
Chart Mitomycin C Segmentation Market Forecast (Region Level) 2019-2024
Chart Mitomycin C Segmentation Market Forecast (Product Type Level) 2019-2024
Chart Mitomycin C Segmentation Market Forecast (Industry Level) 2019-2024
Chart Mitomycin C Segmentation Market Forecast (Channel Level) 2019-2024
Chart 2 Mg Product Figure
Chart 2 Mg Product Advantage and Disadvantage Comparison
Chart 10 Mg Product Figure
Chart 10 Mg Product Advantage and Disadvantage Comparison
Chart 40 Mg Product Figure
Chart 40 Mg Product Advantage and Disadvantage Comparison
Chart Cancer Treatment Clients
Chart Ophthalmic Use Clients
Request Discount 
Inquire Before Buy
